United States : FDA Proposes Broad Approach for Conducting Safety Trials for Type 2 Diabetes Medications

Source :: Mena Report. March 14, 2020
Publication Year :: 2020
Abstract: The U.S. Food and Drug Administration today issued a new draft guidance, Type 2 Diabetes Mellitus: Evaluating the Safety of New Drugs for Improving Glycemic Control, to solicit public comment [...]

Subjects :: United States. Food and Drug Administration
Hypoglycemic agents
Disease susceptibility -- Drug therapy
Type 2 diabetes -- Drug therapy
Diabetes therapy
Drug approval
Independent regulatory commissions
Cardiovascular diseases -- Drug therapy
Chronic kidney failure -- Drug therapy
Blood flow
Diabetes mellitus
Diseases
Kidney diseases
Drugs
Business, international

Tools